Diabetic Foot Ulcer Market Driven By Organogenesis, MiMedx, Kerecis, URGO, Mölnlycke Health Care AB

According to our new research study on “Diabetic Foot Ulcer Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Ulcer Type, and End-User,” the market is expected to reach US$ 7,793.83 million by 2028 from US$ 4,279.65 million in 2020; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the diabetic foot ulcer market is mainly attributed to the factors such as the increasing prevalence of diabetes and related chronic wounds and rising geriatric population. However, the high cost of advanced wound care treatments hinders the market growth.

Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00022321/?utm_source=OpenPR&utm_medium=10144

ConvaTec Inc; 3M Company (Acelity L.P. Inc.); Coloplast A/S; Smith & Nephew plc; B. Braun Melsungen AG; Medline Industries, Inc; Cardinal Health Inc; Organogenesis Holdings Inc; Mölnlycke Health Care; MiMedx Group, Inc; Kerecis hf; and URGO are among the leading companies operating in the diabetic foot ulcer market.

Based on type, the diabetic foot ulcer market is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2020, and it is expected to retain its dominance during the forecast period. The advanced wound care dressings offer more benefits than the traditional methods, such as gauze and tape. The advantages of advanced wound care dressings comprise faster healing time, less issues regarding drainage, and in certain instances, less risk of infection.

Diabetic foot ulcer is a frequent complication in diabetic patients, and it may lead to leg amputation. Diabetes patients, who rely on insulin as a part of diabetes therapy, are at a higher risk of developing a foot ulcer. Diabetic foot ulcers can also affect patients who have diabetes-related kidney, skin, or heart disease, as well as obesity. Also, people who consume alcohol have a higher risk of developing the diabetic foot ulcer. The growth of the diabetic foot ulcer market is attributed to the factors such as the increasing prevalence of diabetes and related chronic wounds and rising geriatric population. However, the high cost of advanced wound care treatments hinders the market growth.

North America was ~46 million in 2017, and it is expected to reach 62 million by 2045, with the disease prevalence of ~35% during 2018–2045. Diabetes affects many parts of the body, particularly the feet. Diabetic foot ulcers are sores developed on feet; they can also develop from seemingly trivial injuries to the feet. Diabetic foot ulcers are the common causes of amputation due to diabetes.

Diabetic Foot Ulcer Market – by Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Rest of Europe
Asia Pacific (APAC)
China
India
South Korea
Japan
Australia
Rest of Asia Pacific
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Place an Order Copy at: https://www.theinsightpartners.com/buy/TIPRE00022321/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.